北陆药业：目前公司持有医未医疗14.9881%股份

Group 1 - The core point of the article is that Beilu Pharmaceutical (300016) holds a 14.9881% stake in Yiwei Medical, making it the second-largest shareholder [1] Group 2 - Beilu Pharmaceutical's investment in Yiwei Medical indicates a strategic positioning within the healthcare sector [1] - The interaction with investors highlights the company's transparency and engagement in shareholder communication [1]